Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Other Non Operating Income (2016 - 2026)

Ekso Bionics Holdings has reported Other Non Operating Income over the past 13 years, most recently at $21000.0 for Q4 2025.

  • On a quarterly basis, Other Non Operating Income rose 101.49% to $21000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $14000.0, a 101.45% increase, with the full-year FY2025 number at $1000.0, up 100.1% from a year prior.
  • Other Non Operating Income reached $21000.0 in Q4 2025 per EKSO's latest filing, up from -$8000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $2.1 million in Q2 2021, with the low at -$1.4 million in Q4 2024.
  • The 5-year median for Other Non Operating Income is -$500.0 (2022), against an average of -$89888.9.
  • Peak YoY movement for Other Non Operating Income: tumbled 1200.0% in 2023, then soared 1415.38% in 2024.
  • Tracing EKSO's Other Non Operating Income over 5 years: stood at -$1.1 million in 2021, then increased by 6.72% to -$1.0 million in 2022, then skyrocketed by 161.0% to $635000.0 in 2023, then tumbled by 321.26% to -$1.4 million in 2024, then soared by 101.49% to $21000.0 in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at $21000.0, -$8000.0, and $1000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.